In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...
News-Medical.Net on MSN
Innovative CRISPR strategy resensitizes lung cancer to treatment
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...
Biocartis Showcases Growing Impact of Idylla™ Platform at AMP 2025Multiple abstracts and a corporate workshop highlight Idylla™’s growing role in oncology diagnostics Itasca, IL, United States, 14 ...
Beyond a cancer cell’s genetic blueprint, the expression levels of certain proteins on its surface is emerging as a collection of critical, actionable biomarkers. Instead of looking for a mutated gene ...
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that ...
ChristianaCare’s Gene Editing Institute says it has found a way to reverse chemotherapy resistance in one of the most common ...
AAV-SLB101 is a rationally designed capsid developed for enhanced skeletal muscle, cardiac tropism, and reduced biodistribution to the liver.
The study investigates partitioning, adsorption, and electrostatic interactions in HILIC, focusing on nucleoside retention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback